MPD: List measures where strain C57BLKS/J is an outlier

List measures where C57BLKS/J is an outlier

Click on pulldowns below to see C57BLKS/J means with summary statistic tooltips.
Within each pulldown, the "up" and "down" triangles indicate when this strain is an outlier.
You can also download all phenotypes for this strain and sort by Z score in Excel.

Sort/ Pick	Data set	Procedure / Protocol	Treatment	Phenotype Measure / Variable (click to view)	Panel	No. of Strains	Sex	Age	Sample Size (Avg)	Year
Berndt1:21	Berndt1	ventilator	methacholine	airway resistance (as % of baseline, H₂O pressure) [%] pct_res 34221 MCh challenge (mg/mL): 1 3 10 30	inbred	37	both	9-12wks	N=8	2010

Brugnara1:2	Brugnara1	ion transport assessment	(none)	RBC potassium cation content (mmol/kg hemoglobin) [mmol/kg] potassium 47402	inbred	10	both	8wks	N=31	2013

Hawes1:10	Hawes1	slit lamp	(none)	corneal opacity, diffuse [frequency rate] cornea_diffuse 26710	inbred w/CC7	41	both	6-7wks	N=10	2008

Jax5:3	Jax5	colony observation	(none)	mean interval between consecutive litters per dam [d] mean_interval 31403	inbred	35	f	6-40wks	N=44	2009

Kumar4:10	Kumar4	gait analysis	(none)	lateral displacement of base of tail keypoint, variance base_tail_lateral_displacement_var 114440	inbred w/CC8	62	both	10-20wks	N=19	2021

Kumar4:35	Kumar4	gait analysis	(none)	lateral displacement of tip of tail keypoint, mean tip_tail_lateral_displacement_mean 114465	inbred w/CC8	62	both	10-20wks	N=19	2021

Maurer1:5	Maurer1	ECG	atenolol, isoproterenol	heart rate [n/min] HR 33205 control atenolol 10mg isoprot 1mg isoprot 10mg	inbred	23	m	7-13wks	N=10	2009

Maurer1:37	Maurer1	ECG	atenolol, isoproterenol	interval RR [ms] RR 33237 control atenolol 10mg isoprot 1mg isoprot 10mg	inbred	23	m	7-13wks	N=10	2009

Paigen1:25	Paigen1	metabolic panel	high-fat diet	bile salts (plasma) [µmol/L] bilesalts 2925	inbred	43	both	15-19wks	N=8	2000

Paigen2:24	Paigen2	histopathology	high-fat diet	fatty streak aortic lesion size [µm²] aortic_lesion 9924	inbred w/CC7	42	both	25-27wks	N=9	2002

Peters1:1	Peters1	complete blood count	(none)	white blood cell count (WBC; per volume x 10³) [n/µL] WBC 6201	inbred w/CC7	43	both	10wks	N=12	2001

Peters1:16	Peters1	complete blood count	(none)	basophil differential (percent of total WBC) [%] BASO 6216	inbred w/CC7	43	both	10wks	N=11	2001

Peters4:17	Peters4	complete blood count	(none)	monocyte count (MONO; units per volume x 10³) [n/µL] MONO 24317 6mo 12mo 18mo 24mo	inbred	30	both		N=7	2007

Peters4:21	Peters4	complete blood count	(none)	eosinophil count (EOS; units per volume x 10³) [n/µL] EOS 24321 6mo 12mo 18mo 24mo	inbred	30	both		N=7	2007

Peters4:29	Peters4	complete blood count	(none)	large unstained cells count (LUC; units per volume x 10³) [n/µL] LUC 24329 6mo 12mo 18mo 24mo	inbred	30	both		N=7	2007

Petkova1:1	Petkova1	immune cell quantification	(none)	white blood cell count (WBC; per volume x 10³) [n/µL] WBC 24201 6mo 12mo 18mo 24mo	inbred	32	both		N=7	2007

Petkova1:37	Petkova1	immune cell quantification	(none)	CD4 T cells, central memory, as percentage of total CD4 T cells [%] CD4_mem_central 24237 6mo 12mo 18mo 24mo	inbred	32	both		N=8	2007

Wiltshire3:25	Wiltshire3	biomarker quantification	fluoxetine	cerebral cortex GAL, relative fluorescence intensity GAL 38125 control fluoxetine change index	inbred	30	m	10-11wks	N=3	2011

Wiltshire4:13	Wiltshire4	immune cell quantification	BEZ235	monocytes, percent viability [%] monocytes_BEZ 52413 dose [µM]: control 0.046 0.137 1.235 11.1 100	inbred w/CC7	34	m	10wks	N=4	2015

Wiltshire4:33	Wiltshire4	immune cell quantification	doxorubicin	monocytes, percent viability [%] monocytes_Dox 52433 dose [µM]: control 0.046 0.137 1.235 11.1 100	inbred w/CC7	35	m	10wks	N=4	2015

Wiltshire4:47	Wiltshire4	immune cell quantification	idarubicin	T cells, percent viability [%] Tcells_Ida 52447 dose [µM]: control 0.046 0.137 1.235 11.1 100	inbred w/CC7	35	m	10wks	N=4	2015

Wiltshire4:53	Wiltshire4	immune cell quantification	idarubicin	monocytes, percent viability [%] monocytes_Ida 52453 dose [µM]: control 0.046 0.137 1.235 11.1 100	inbred w/CC7	35	m	10wks	N=4	2015

Xing2:4	Xing2	gait analysis	(none)	gait score (1-3) [score] gait_score 36304 6mo 12mo 18mo	inbred	31	both		N=7	2010

Yuan3:66	Yuan3	metabolic panel	(none)	bilirubin (serum TBIL) [µmol/L] TBIL 24466 6mo 12mo 18mo	inbred	32	both		N=7	2008

List measures where C57BLKS/J is an outlier

Filter Table Results